CIK 0001698530
- Non-accelerated filer
- Smaller reporting company
EXICURE, INC.
Sign in to watch- Ticker
- XCUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 815333008
- Phone
- +1 847-673-1707
- Business address
- 2430 N. HALSTED ST., CHICAGO, IL, 60614
- Former names
- Max-1 Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-26 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +12,929 | 12,929 | ||
| 2017-09-26 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +24,824 | 24,824 | ||
| 2017-09-26 | Kandimalla Ekambarswara R Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +281,915 | 281,915 | ||
| 2017-09-22 | Jacobs Ian Seth President, Secretary, CEO, CFO | Grant or award | +38,160 | 103,160 | ||
| 2017-09-22 | Tompkins Mark N. Director | Grant or award | +659,000 | 1,659,000 | ||
| 2017-09-22 | Tompkins Mark N. Director | Grant or award | +43,160 | 108,160 | ||
| 2017-06-15 | Tompkins Mark N. Director | Grant or award | +65,000 | $0.03 | $2K | 965,000 |
| 2017-06-15 | Tompkins Mark N. Director | Purchase | +35,000 | $0.03 | $875 | 1,000,000 |
| 2017-06-15 | Tompkins Mark N. Director | Grant or award | +65,000 | $0.03 | $2K | 65,000 |
| 2017-06-15 | Jacobs Ian Seth President, Secretary, CEO, CFO | Sale | −35,000 | $0.03 | $875 | 65,000 |
Page 8 of 8 · 150 trades